BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6732234)

  • 1. In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers.
    Barry AL; Jones RN; Ayers LW; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1984 May; 25(5):669-71. PubMed ID: 6732234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilli.
    Fass RJ; Helsel VL
    Antimicrob Agents Chemother; 1984 Nov; 26(5):660-4. PubMed ID: 6440476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro activities of cefpiramide and apalcillin individually and in combination.
    Allan JD; Eliopoulos GM; Ferraro MJ; Moellering RC
    Antimicrob Agents Chemother; 1985 May; 27(5):782-90. PubMed ID: 3925875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates.
    Noguchi H; Kubo M; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1978 May; 13(5):745-52. PubMed ID: 248269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jun; 21(6):906-11. PubMed ID: 6981375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study].
    Quentin C; Auzerie J; Bebear C; Acar JF; Kitzis MD; Avril JL; Moillo-Batt A; Shacoori Z; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1984 May; 32(5):301-6. PubMed ID: 6429608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
    Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of apalcillin against Pseudomonas aeruginosa.
    Hollick GE; Gundrum J; Venezia RA
    Antimicrob Agents Chemother; 1984 Sep; 26(3):408-9. PubMed ID: 6439115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibacterial activity of apalcillin against 300 strains of enterobacteria].
    Coulet M; Forey F; Brun Y; Fleurette J
    Pathol Biol (Paris); 1983 May; 31(5):311-8. PubMed ID: 6353323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.
    Barry AL; Thornsberry C; Jones RN; Gavan TL
    J Clin Microbiol; 1984 Jun; 19(6):777-82. PubMed ID: 6432833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activities of cefpiramide and apalcillin against anaerobic bacteria.
    Wexler H; Carter WT; Harris B; Finegold SM
    Antimicrob Agents Chemother; 1984 Feb; 25(2):162-4. PubMed ID: 6712200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of piperacillin compared with that of carbenicillin, ticarcillin, ampicillin, cephalothin, and cefamandole against Pseudomonas aeruginosa and Enterobacteriaceae.
    Shah PP; Briedis DJ; Robson HG; Conterato JP
    Antimicrob Agents Chemother; 1979 Mar; 15(3):346-50. PubMed ID: 111609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
    Greenwood D; Eley A
    J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative sensitivity of 207 strains of strict anaerobic bacteria to piperacillin and 4 other antibiotics].
    Reynaud A; Drugeon HB; Derriennic M; Courtieu AL
    Pathol Biol (Paris); 1985 Nov; 33(9):891-5. PubMed ID: 3909081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A microbiological evaluation of apalcillin.
    Wiedemann B; Seeberg A
    Infection; 1983; 11(6):340-4. PubMed ID: 6421745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Mar; 13(3):358-67. PubMed ID: 122519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin.
    Monif GR; Clark PR; Shuster JJ; Baer H
    Antimicrob Agents Chemother; 1978 Nov; 14(5):643-9. PubMed ID: 103491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.